A Study to Compare the Safety and Tolerability of Sativex® in Patients With Neuropathic Pain.

Status:
Completed

Trial end date:
2007-06-01

Target enrollment:

Participant gender:

The purpose of this study is to assess the safety and tolerability of long term therapy with Sativex® in relieving neuropathic pain.

Phase 3

GW Pharmaceuticals Ltd.

Nabiximols